INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 38 filers reported holding INFLARX NV in Q2 2020. The put-call ratio across all filers is 6.86 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $0 | – | 2 | -93.3% | 0.00% | – |
Q2 2021 | $0 | – | 30 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 30 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 30 | 0.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 30 | -95.9% | 0.00% | – |
Q2 2020 | $3,000 | – | 730 | +630.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 100 | -99.8% | 0.00% | – |
Q4 2019 | $198,000 | +59.7% | 50,000 | 0.0% | 0.00% | – |
Q3 2019 | $124,000 | -60.8% | 50,000 | -50.0% | 0.00% | – |
Q2 2019 | $316,000 | +2330.8% | 100,000 | +24900.0% | 0.00% | – |
Q2 2018 | $13,000 | -91.0% | 400 | -92.0% | 0.00% | – |
Q1 2018 | $144,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,764,888 | $60,571,000 | 13.75% |
RA Capital Management | 1,967,848 | $67,537,000 | 3.61% |
Cormorant Asset Management, LP | 1,341,540 | $46,042,000 | 2.99% |
Redmile Group, LLC | 2,024,900 | $69,495,000 | 2.14% |
EMORY UNIVERSITY | 90,437 | $3,104,000 | 2.03% |
Artal Group S.A. | 500,000 | $17,160,000 | 0.45% |
Birchview Capital, LP | 16,000 | $549,000 | 0.35% |
Eventide Asset Management | 275,000 | $9,438,000 | 0.35% |
Rock Springs Capital Management LP | 177,500 | $6,092,000 | 0.22% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,551,959 | $87,583,000 | 0.20% |